Aclarion, Inc.

NasdaqCM ACON

Aclarion, Inc. Total Assets for the quarter ending September 30, 2024

Aclarion, Inc. Total Assets is NA for the quarter ending September 30, 2024. Total assets are the total value of all assets owned by a company, representing its resources.

Aclarion, Inc. Total Assets for the quarter ending September 30, 2021 was USD 2.65 M.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

NasdaqCM: ACON

Aclarion, Inc.

CEO	Mr. Brent Ness
IPO Date	April 22, 2022
Location	United States
Headquarters	951 Mariners Island Boulevard
Employees	4
Sector	Healthcare
Industries Biotechnology 3D Printing Clinical Trials Database Medical Instruments Pharmaceuticals Software-as-a-Service (SaaS) Telehealth

Description

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Key trends

Past 5 years